Owlet Gestione
Criteri Gestione verificati 4/4
Owlet Il CEO è Kurt Workman, nominato in Jan2012, e ha un mandato di 14.5 anni. la retribuzione annua totale è $ 799.41K, composta da 37.5% di stipendio e 62.5% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 2% delle azioni della società, per un valore di $ 3.05M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3 anni e 5.4 anni.
Informazioni chiave
Kurt Workman
Amministratore delegato
US$799.4k
Compenso totale
| Percentuale dello stipendio del CEO | 37.53% |
| Mandato del CEO | 14.5yrs |
| Proprietà del CEO | 2.0% |
| Durata media del management | 3yrs |
| Durata media del Consiglio di amministrazione | 5.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Aggiornamento narrativa • Jul 24
OWLT: Customer Adoption And Subscriptions Will Drive Future Upside Potential
Owlet's updated analyst price target shifts from $20 to $15 as analysts factor in revised growth expectations, slightly adjusted discount rates, and a lower future P/E multiple, while still highlighting the potential for upside from increased customer adoption and subscriptions. What’s in the News for Owlet Owlet, Inc.
Aggiornamento narrativa • Jul 10
OWLT: Guidance Reset And Subscriptions Are Expected To Drive Upside
Analysts have lowered their price target on Owlet stock from $13 to $10, reflecting a reset in expectations while still highlighting what they see as an underappreciated brand with potential for upside as customer adoption and subscription features develop. What’s in the News for Owlet Owlet, Inc.Seeking Alpha • Jul 08
Owlet: Changes Galore As Co-Founder Takes The Reins Once Again (Rating Upgrade)
Summary Owlet shifts strategy under returning CEO Workman, prioritizing subscriptions and telehealth over hardware for multi-year recurring revenue. OWLT narrows its geographic focus to the U.S. and Europe, exits low-margin Asian markets, and aims for profitability by leveraging AI-driven efficiencies. Q1 2026 revenue grew 6% to $23M, but operating losses widened; management lowered full-year revenue guidance but raised adjusted EBITDA outlook. Despite improved liquidity via a $25M credit facility and attractive valuation, I remain cautious given ongoing going concern risks and uncertain execution. Read the full article on Seeking Alpha
Aggiornamento narrativa • Jun 26
OWLT: Guidance Reset And Adoption Initiatives Will Support Future Execution
Analysts have trimmed their fair value estimate for Owlet from $17.00 to $13.00, reflecting updated assumptions on growth, profitability, and P/E, while still pointing to potential upside supported by views that the recent guidance reset and improving hardware and subscription features could attract more customers over time. What's in the News for Owlet Owlet launched Dream Sight and Dream Duo 3 across Australia and New Zealand, bringing its full lineup of baby monitoring products, including Dream Sock, to those markets for the first time.Aggiornamento narrativa • Jun 04
OWLT: Softer Q1 Guide Seen Preceding Stronger 2026 Second Half
Narrative Update The analyst price target for Owlet has been reduced from $20 to $15, with analysts pointing to softer Q1 guidance, while also noting 2026 expectations that suggest a more robust back half of that year. What's in the News Owlet launched Dream Sight and Dream Duo 3 across Australia and New Zealand, expanding its full baby monitoring product lineup in those markets, including Dream Sock, Dream Sight, and Dream Duo 3.Aggiornamento narrativa • May 11
OWLT: Softer Q1 Outlook Seen Setting Up Stronger 2026 Finish
Analysts have trimmed their price target on Owlet stock to $15 from $20, citing Q1 guidance that came in below expectations, while highlighting that 2026 guidance still lines up with prior views and points to a potentially stronger second half of that year. Analyst Commentary Bearish analysts are signaling a more cautious stance on Owlet after recent guidance, using the reduced price target as a way to reset expectations while still acknowledging longer term potential.Aggiornamento narrativa • Apr 20
OWLT: Softer Q1 Outlook Expected To Set Up Stronger Second Half 2026
Analysts have lowered their price target on Owlet to $15 from $20, citing slightly softer Q1 guidance versus expectations. They also note that current management guidance indicates the second half of 2026 could be more robust.Aggiornamento narrativa • Apr 05
OWLT: Guidance And Partnerships Are Expected To Support A Stronger Second Half 2026
Analysts have revised Owlet's price target to $15, down from $19, reflecting mixed near term guidance and updated models that still indicate the possibility of stronger performance in the longer term. Analyst Commentary Recent research updates on Owlet point to a more cautious tone, even as some longer term expectations remain in place.Aggiornamento narrativa • Mar 22
OWLT: Updated Modeling And Healthcare Partnerships Will Support Stronger Second Half 2026
Analysts have updated their view on Owlet, trimming the consolidated price target to $15 as they factor in softer Q1 guidance, a higher assumed P/E multiple and lower projected revenue growth and profit margins, while still highlighting expectations for a stronger second half of 2026. Analyst Commentary Recent research highlights a more measured tone around Owlet, with some price targets recalibrated as analysts balance solid past execution with softer near term guidance and updated valuation assumptions.Aggiornamento narrativa • Mar 08
OWLT: Updated Modeling And New Healthcare Partnerships Will Support Future Upside Potential
Analysts have adjusted their outlook on Owlet, trimming the price target from $14 to $13 as they factor in updated expectations for growth, profitability, and future P/E assumptions that are informed by recent research highlighting mixed near term guidance alongside longer term projections that are described as steady. Analyst Commentary Recent Street research reflects a mixed but increasingly cautious tone around Owlet, with some bearish analysts trimming price targets as they reassess growth visibility and execution risk against current valuation.Aggiornamento narrativa • Feb 22
OWLT: Updated Modeling And FDA Pathways Will Support Future Upside Potential
Analysts have lifted their price target on Owlet to $19 from $15, citing updated modeling assumptions following a transfer of coverage. Analyst Commentary Recent research points to a reset in expectations around Owlet, with updated modeling used to support a US$19 price target.Aggiornamento narrativa • Feb 07
OWLT: Additional Liquidity And Partnerships Will Extend Funding Runway
Analysts have lifted their price target on Owlet to US$20 from US$15, citing updated models that factor in recent Street research highlighting a refreshed coverage framework and additional liquidity that supports the company’s plans. Analyst Commentary Bullish analysts are pointing to recent price target revisions as a sign of growing confidence in Owlet’s ability to execute on its plans, especially as fresh research coverage and additional liquidity are incorporated into updated models.Articolo di analisi • Feb 05
Some Owlet, Inc. (NYSE:OWLT) Shareholders Look For Exit As Shares Take 31% Pounding
Owlet, Inc. ( NYSE:OWLT ) shares have retraced a considerable 31% in the last month, reversing a fair amount of their...Aggiornamento narrativa • Jan 24
OWLT: Liquidity And New Coverage Models Will Support Future Execution
Narrative Update: Owlet Analyst Price Target Shift Analysts have lifted their price target on Owlet from US$16 to US$17, reflecting updated models that factor in recent target increases on the Street and comfort with assumptions around fair value, discount rate, and a higher future P/E multiple. Analyst Commentary Recent Street research has tilted constructive on Owlet, with bullish analysts lifting price targets and updating their models following new company information and a transfer of coverage.Aggiornamento narrativa • Jan 09
OWLT: Liquidity And Regulatory Progress Will Support Execution While Risks Remain
Analysts have lifted their price target on Owlet to US$16.00 from US$14.88, citing refreshed models that factor in recent price target increases from firms updating coverage and highlighting added liquidity to support R&D into 2026. Analyst Commentary Recent Street research has trended constructive on Owlet, with higher price targets reflecting refreshed coverage models and a focus on liquidity and execution into 2026.Aggiornamento narrativa • Dec 15
OWLT: FDA Focus And Global Expansion Will Shape Balanced Risk Profile
Analysts have raised their fair value estimate for Owlet from $11.00 to $14.00 per share, citing stronger projected revenue growth, improved liquidity from a recent stock offering, and an FDA highlighted competitive moat that supports a higher long term price target. Analyst Commentary Recent research commentary has underscored a more constructive outlook on Owlet, with price targets moving higher following what was described as a solid quarter and improved balance sheet flexibility.Articolo di analisi • Dec 05
There's Reason For Concern Over Owlet, Inc.'s (NYSE:OWLT) Massive 67% Price Jump
Owlet, Inc. ( NYSE:OWLT ) shares have continued their recent momentum with a 67% gain in the last month alone. The...Aggiornamento narrativa • Dec 01
OWLT: Regulatory Momentum And FDA Approval Will Drive Market Leadership Forward
Analysts have increased their price target for Owlet to $15.50 from $12.00, citing a solid quarter, improved liquidity, and the company's status as the only FDA-approved over-the-counter infant monitoring device as key drivers for their more favorable outlook. Analyst Commentary Recent analyst perspectives on Owlet reflect a mixed but largely positive sentiment following the company's most recent financial results and regulatory developments.Aggiornamento narrativa • Nov 17
OWLT: Regulatory Approvals And Increased Liquidity Will Support Long-Term Market Leadership
Analysts have raised their price target for Owlet from $13.20 to $14.83. They cite stronger revenue growth, improved profitability, and increased liquidity following the company's solid recent quarter.Articolo di analisi • Oct 07
Further Upside For Owlet, Inc. (NYSE:OWLT) Shares Could Introduce Price Risks After 31% Bounce
Owlet, Inc. ( NYSE:OWLT ) shares have had a really impressive month, gaining 31% after a shaky period beforehand. The...Aggiornamento narrativa • Aug 09
Telehealth Partnerships And AI Insights Will Broaden Digital Health Markets
Driven by strong consumer demand for its FDA-cleared Dream Sock and a unique competitive position, analysts have raised Owlet’s price target from $12.30 to $13.20. Analyst Commentary The $300 Dream Sock is currently a best-selling smart baby monitor on Amazon, demonstrating strong consumer traction.Articolo di analisi • Jun 14
Investors Still Aren't Entirely Convinced By Owlet, Inc.'s (NYSE:OWLT) Revenues Despite 34% Price Jump
Owlet, Inc. ( NYSE:OWLT ) shares have continued their recent momentum with a 34% gain in the last month alone. The last...
Nuova narrativa • Apr 10
Dream Sock, BabySat, And Company360 Will Expand Global Healthcare Access
Owlet's FDA and CE approvals pave the way for global market expansion, boosting international revenue potential.Articolo di analisi • Oct 18
Many Still Looking Away From Owlet, Inc. (NYSE:OWLT)
Owlet, Inc.'s ( NYSE:OWLT ) price-to-sales (or "P/S") ratio of 1x might make it look like a strong buy right now...Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Utili della società |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$48m |
| Dec 31 2025 | US$799k | US$300k | -US$42m |
| Sep 30 2025 | n/a | n/a | -US$42m |
| Jun 30 2025 | n/a | n/a | -US$52m |
| Mar 31 2025 | n/a | n/a | -US$17m |
| Dec 31 2024 | US$987k | US$375k | -US$17m |
| Sep 30 2024 | n/a | n/a | -US$11m |
| Jun 30 2024 | n/a | n/a | -US$11m |
| Mar 31 2024 | n/a | n/a | -US$19m |
| Dec 31 2023 | US$269k | US$267k | -US$33m |
| Sep 30 2023 | n/a | n/a | -US$49m |
| Jun 30 2023 | n/a | n/a | -US$61m |
| Mar 31 2023 | n/a | n/a | -US$63m |
| Dec 31 2022 | US$5m | US$369k | -US$79m |
| Sep 30 2022 | n/a | n/a | -US$84m |
| Jun 30 2022 | n/a | n/a | -US$99m |
| Mar 31 2022 | n/a | n/a | -US$93m |
| Dec 31 2021 | US$2m | US$330k | -US$72m |
Compensazione vs Mercato: La retribuzione totale di Kurt ($USD 799.41K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.64M ).
Compensazione vs guadagni: La retribuzione di Kurt è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Kurt Workman (36 yo)
14.5yrs
Mandato
US$799,405
Compensazione
Mr. Kurt Workman co-founded Owlet Baby Care Inc. (formerly Owlet Baby Care LLC) in 2012 and served as the Chief Executive Officer from its founding in 2012 until December 2019. He was President of Owlet, I...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 14.5yrs | US$799.41k | 2% $ 3.0m | |
| Chief Financial Officer | 2yrs | US$2.42m | 0.57% $ 865.1k | |
| Chief Operating Officer | no data | Nessun dato | Nessun dato | |
| Chief Technology Officer | 4.5yrs | Nessun dato | Nessun dato | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Chief Parent Officer | 3yrs | Nessun dato | Nessun dato | |
| Chief Revenue Officer | 1.1yrs | Nessun dato | Nessun dato |
3.0yrs
Durata media
Gestione esperta: Il team dirigenziale di OWLT è considerato esperto (durata media dell'incarico 3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-Founder | 14yrs | US$799.41k | 2% $ 3.0m | |
| Independent Director | 5.3yrs | US$213.37k | 0.31% $ 467.3k | |
| Independent Director | 5.4yrs | US$245.87k | 0.28% $ 428.8k | |
| Independent Director | 5.3yrs | US$213.37k | 0.80% $ 1.2m | |
| Independent Director | 2.9yrs | US$213.37k | Nessun dato | |
| Independent Chairman of the Board | 11yrs | Nessun dato | Nessun dato | |
| Independent Director | 3yrs | US$213.37k | 0.24% $ 361.8k | |
| Independent Director | 8.3yrs | Nessun dato | Nessun dato |
5.4yrs
Durata media
55yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di OWLT sono considerati esperti (durata media dell'incarico 5.4 anni).
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/31 07:50 |
| Prezzo dell'azione a fine giornata | 2026/07/31 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Owlet, Inc. è coperta da 8 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Allen Lutz | BofA Global Research |
| James Suva | Citigroup Inc |
| Ilya Zubkov | Freedom Broker |